CynoGen, Inc.
CynoGen, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in 2018, the company has rapidly established itself in the fields of personalised medicine and advanced therapeutics, focusing on innovative solutions for complex health challenges. CynoGen's core offerings include cutting-edge gene therapies and regenerative medicine products, distinguished by their commitment to enhancing patient outcomes through tailored treatments. The company has achieved significant milestones, including collaborations with leading research institutions, positioning itself as a notable player in the biotech landscape. With a strong emphasis on research and development, CynoGen continues to push the boundaries of medical science, striving to transform the future of healthcare.
DitchCarbon Score
How does CynoGen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CynoGen, Inc.'s score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CynoGen, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of NeoGenomics, Inc., which may influence its climate commitments and reporting practices. As of now, CynoGen has not established any documented reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). This lack of publicly available data suggests that CynoGen may still be in the early stages of developing its climate strategy. Given the absence of specific emissions data and reduction commitments, it is essential for CynoGen to consider implementing robust sustainability practices and setting measurable targets to align with industry standards and expectations. This would not only enhance their environmental responsibility but also improve their standing within the biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 536,000 |
| Scope 2 | 4,181,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CynoGen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
